JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Endoscopic ultrasound-guided biliary interventions: an update on recent developments.

PURPOSE OF REVIEW: Endoscopic ultrasound (EUS)-guided biliary drainage procedures can be utilized in patients with biliary obstruction and incomplete drainage with prior interventions, in those whose ampulla is inaccessible (i.e. from surgically altered anatomy and malignant luminal obstruction), or in those who failed bile duct cannulation during endoscopic retrograde cholangiopancreatography. Improved techniques and accessories have streamlined these procedures; however, further investigation is required. The purpose of this review is to provide the highlights of the most recent literature on EUS-guided biliary drainage.

RECENT FINDINGS: Recent literature has demonstrated the effectiveness and safety of EUS-guided gallbladder drainage, both as a primary intervention in patients with cholecystitis who are unfit for urgent surgical intervention and as a secondary intervention to internalize biliary drainage after initial placement of a cholecystostomy catheter. EUS-guided bile duct drainage can be performed using various techniques. The optimal technique requires further study and may vary by clinical scenario.

SUMMARY: The role of EUS-guided biliary drainage continues to evolve. The most recent literature has attempted to clarify the optimal strategies and indications for employing the various EUS-guided biliary drainage techniques.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app